Last reviewed · How we verify

acetaminophen plus codeine

Nova Scotia Health Authority · Phase 3 active Small molecule

Acetaminophen acts as a non-selective COX inhibitor, while codeine exerts its effects through opioid receptors.

Acetaminophen acts as a non-selective COX inhibitor, while codeine exerts its effects through opioid receptors. Used for Pain relief, Cough suppression.

At a glance

Generic nameacetaminophen plus codeine
SponsorNova Scotia Health Authority
Drug classOpioid analgesic
TargetOpioid receptors
ModalitySmall molecule
Therapeutic areaPain management
PhasePhase 3

Mechanism of action

Acetaminophen's mechanism of action involves the inhibition of cyclooxygenase enzymes, which are responsible for the production of prostaglandins. This leads to a reduction in pain and fever. Codeine, on the other hand, is an opioid agonist that binds to opioid receptors in the brain, spinal cord, and other areas, producing analgesia and sedation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: